Amgen Inc. Announces Appointment of Linda H. Louie as Vice President, Finance and Chief Accounting Officer

Amgen, one of the world’s leading biotechnology companies, appointed Linda H. Louie, to serve as the Company’s Vice President, Finance and Chief Accounting Officer (“CAO”), effective immediately. Ms. Louie will be the Company’s principal accounting officer; she will not be an executive officer of the Company. Ms. Louie previously served as the Company’s Executive Director Accounting since June 2015 and was Director of Finance at the Company from April 2011 to June 2015.

Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illness. They are a $23.4 billion company with 22,000 employees worldwide. Amgen’s headquarters is in Thousand Oaks, California.